1. Home
  2. TANH vs RDHL Comparison

TANH vs RDHL Comparison

Compare TANH & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

HOLD

Current Price

$1.00

Market Cap

6.2M

Sector

N/A

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$1.22

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
RDHL
Founded
2001
2009
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.6M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TANH
RDHL
Price
$1.00
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
49.7K
1.3M
Earning Date
05-15-2026
09-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.88
N/A
Revenue
$41,982,988.00
$9,550,000.00
Revenue This Year
N/A
$381.91
Revenue Next Year
N/A
N/A
P/E Ratio
$0.19
N/A
Revenue Growth
N/A
157.62
52 Week Low
$0.90
$0.91
52 Week High
$6.98
$6.80

Technical Indicators

Market Signals
Indicator
TANH
RDHL
Relative Strength Index (RSI) 44.56 50.88
Support Level $0.98 $1.17
Resistance Level $1.05 $1.38
Average True Range (ATR) 0.07 0.10
MACD 0.01 0.01
Stochastic Oscillator 62.46 61.99

Price Performance

Historical Comparison
TANH
RDHL

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: